• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment.

作者信息

Muniyan Sakthivel, Li Benyi, Batra Surinder K

机构信息

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States.

Department of Urology, University of Kansas Medical Center, Kansas City, KS, United States.

出版信息

Front Oncol. 2022 May 13;12:913630. doi: 10.3389/fonc.2022.913630. eCollection 2022.

DOI:10.3389/fonc.2022.913630
PMID:35646644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9136391/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/533c/9136391/3bf60f8e3441/fonc-12-913630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/533c/9136391/3bf60f8e3441/fonc-12-913630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/533c/9136391/3bf60f8e3441/fonc-12-913630-g001.jpg

相似文献

1
Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment.社论：转移性去势抵抗性前列腺癌：预后与治疗
Front Oncol. 2022 May 13;12:913630. doi: 10.3389/fonc.2022.913630. eCollection 2022.
2
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275).前瞻性评估 mCRPC 患者循环肿瘤细胞中 AR 剪接变体和 PSMA 的检测：PRIMERA 试验（NCT04188275）入组患者的初步分析。
Clin Exp Metastasis. 2021 Oct;38(5):451-458. doi: 10.1007/s10585-021-10118-7. Epub 2021 Aug 19.
3
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).接受雄激素受体靶向药物治疗的 mCRPC 患者循环肿瘤细胞中 AR 剪接变体和多生物标志物表达的前瞻性评估：PRIMERA 试验的中期分析（NCT04188275）。
Med Oncol. 2022 Jun 10;39(8):119. doi: 10.1007/s12032-022-01756-2.
4
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving Lu-PSMA-617 Radioligand Therapy.转移性去势抵抗性前列腺癌患者接受 Lu-PSMA-617 放射性配体治疗时循环肿瘤细胞的分子分析。
Theranostics. 2020 Jun 18;10(17):7645-7655. doi: 10.7150/thno.44556. eCollection 2020.
5
Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.恩杂鲁胺治疗的骨转移性去势抵抗性前列腺癌的分子特征
Eur Urol. 2015 Jan;67(1):53-60. doi: 10.1016/j.eururo.2014.05.005. Epub 2014 May 29.
6
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer.镥-PSMA-I&T 放射性配体治疗转移性去势抵抗性前列腺癌的治疗结果、毒性和预测因素。
Eur Urol. 2019 Jun;75(6):920-926. doi: 10.1016/j.eururo.2018.11.016. Epub 2018 Nov 22.
7
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial).转移性去势抵抗性前列腺癌患者循环肿瘤细胞中AR/ARV7表达的分析（SAKK 08/14 IMPROVE试验）
Cancers (Basel). 2019 Aug 1;11(8):1099. doi: 10.3390/cancers11081099.
8
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.镥-177-PSMA 治疗失败后的晚期转移性去势抵抗性前列腺癌中锕-225-PSMA-617 的活性和不良事件
Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5.
9
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8 T-cells Derived from Patients with Metastatic Castrate-resistant Disease.针对转移性去势抵抗性疾病患者来源的、前列腺特异性膜抗原特异性、转化生长因子-β 不敏感的基因靶向 CD8 T 细胞对人前列腺癌的疗效。
Eur Urol. 2018 May;73(5):648-652. doi: 10.1016/j.eururo.2017.12.008. Epub 2017 Dec 21.
10
Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer.早期使用雄激素受体轴靶向药物可能会提高非转移性去势抵抗性前列腺癌患者的总生存率。
Prostate. 2018 Jul;78(10):766-772. doi: 10.1002/pros.23534. Epub 2018 Apr 10.

引用本文的文献

1
Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager.通过基于VHH的PSMA-Vδ2双特异性T细胞衔接器利用Vγ9Vδ2 T细胞对抗前列腺癌。
iScience. 2024 Oct 30;27(12):111289. doi: 10.1016/j.isci.2024.111289. eCollection 2024 Dec 20.
2
PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer.PAF1介导的转录重编程赋予晚期前列腺癌多西他赛耐药性。
Cancer Lett. 2025 Jan 28;609:217355. doi: 10.1016/j.canlet.2024.217355. Epub 2024 Nov 26.
3
Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling.西地那非通过刺激 NO-cGMP 信号增强多西他赛在晚期前列腺癌中的治疗效果。
Clin Cancer Res. 2020 Nov 1;26(21):5720-5734. doi: 10.1158/1078-0432.CCR-20-1569. Epub 2020 Aug 26.
3
Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.
探索含硫基团在抑制甾体生成化合物中的潜力。
Biomolecules. 2023 Sep 5;13(9):1349. doi: 10.3390/biom13091349.
4
Androgen-deprivation therapy with leuprolide increases abdominal adiposity without causing cardiac dysfunction in middle-aged male mice: effect of sildenafil.用亮丙瑞林进行雄激素剥夺治疗会导致中年雄性小鼠腹部肥胖，而不会导致心脏功能障碍：西地那非的作用。
Am J Physiol Regul Integr Comp Physiol. 2023 Apr 1;324(4):R589-R600. doi: 10.1152/ajpregu.00259.2022. Epub 2023 Mar 6.
5
Identification of the Regulatory Targets of miR-3687 and miR-4417 in Prostate Cancer Cells Using a Proteomics Approach.利用蛋白质组学方法鉴定前列腺癌细胞中 miR-3687 和 miR-4417 的调控靶标。
Int J Mol Sci. 2022 Sep 12;23(18):10565. doi: 10.3390/ijms231810565.
心血管风险和毒性 - 前列腺癌患者去势治疗的阿喀琉斯之踵。
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188383. doi: 10.1016/j.bbcan.2020.188383. Epub 2020 Jun 11.
4
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.去势抵抗性前列腺癌：AUA 指南修订版 2018.
J Urol. 2018 Dec;200(6):1264-1272. doi: 10.1016/j.juro.2018.07.090. Epub 2018 Aug 4.
5
Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.局限性前列腺癌男性根治性前列腺切除术后辅助放疗与早期挽救性放疗的比较
Curr Urol Rep. 2017 Jul;18(7):55. doi: 10.1007/s11934-017-0700-0.